SPONSOR
Gustave Roussy, Cancer Campus, Grand Paris
Total Trials
7
Recruiting
7
Phases
Phase 4, Phase 2, Phase 3
Conditions studied: Kidney CancerRenal Cell CancerHead and Neck Squamous Cell CarcinomaSquamous Cell CarcinomaBreast CancerPancreas CancerColon CancerLynch SyndromeGermline BRCA1 Gene MutationGermline BRCA2 Gene Mutation
Gustave Roussy, Cancer Campus, Grand Paris is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Kidney Cancer, Renal Cell Cancer, Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma.
The trial portfolio spans Phase 4, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Gustave Roussy, Cancer Campus, Grand Paris
How many clinical trials has Gustave Roussy, Cancer Campus, Grand Paris sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Gustave Roussy, Cancer Campus, Grand Paris, of which 7 are actively recruiting participants. These trials cover conditions including Kidney Cancer, Renal Cell Cancer, Head and Neck Squamous Cell Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Gustave Roussy, Cancer Campus, Grand Paris research focus on?
Gustave Roussy, Cancer Campus, Grand Paris clinical trials span Kidney Cancer, Renal Cell Cancer, Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma, Breast Cancer, and additional conditions. The research pipeline includes Phase 4, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Gustave Roussy, Cancer Campus, Grand Paris clinical trial?
To participate in a Gustave Roussy, Cancer Campus, Grand Paris trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Gustave Roussy, Cancer Campus, Grand Paris trials with current recruitment status updated daily.
Clinical Trials by Gustave Roussy, Cancer Campus, Grand Paris
NCT06934057 Phase 4
Recruiting
Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma
Kidney Cancer
NCT03406247 Phase 2
Recruiting
Adjuvant Immunotherapy After Salvage Surgery in Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
NCT04224389
Recruiting
IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas
Squamous Cell Carcinoma
NCT07436312
Recruiting
Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer
Breast Cancer
NCT05267912
Recruiting
Prospective Multicenter Study Evaluating Feasibility and Efficacy of Tumor Organoid-based Precision Medicine in Patients With Advanced Refractory Cancers
Advanced, Pretreated Solid Tumors
NCT05631249 Phase 2
Recruiting
Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C
KRAS P.G12C
NCT03819101 Phase 3
Recruiting
Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer
Prostate Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology